121 related articles for article (PubMed ID: 38602084)
1. Role of submucosal injection in radiofrequency ablation of gastric low-grade dysplasia: Effects on symptoms and outcomes.
Niu X; Wang N; Wang Y; Feng J; Li L; Han K; Chai N; Linghu E
Chin Med J (Engl); 2024 Apr; ():. PubMed ID: 38602084
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett's Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials.
Wang Y; Ma B; Yang S; Li W; Li P
Front Oncol; 2022; 12():801940. PubMed ID: 35296005
[TBL] [Abstract][Full Text] [Related]
3. Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2011; 11(1):1-93. PubMed ID: 23074413
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett's Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis.
Klair JS; Zafar Y; Nagra N; Murali AR; Jayaraj M; Singh D; Rustagi T; Krishnamoorthi R
Dig Dis; 2021; 39(6):561-568. PubMed ID: 33503615
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Endoscopic Radiofrequency Ablation and Argon Plasma Coagulation in Patients with Gastric Low-Grade Intraepithelial Neoplasia: A Large-Scale Retrospective Study.
Wang N; Chai N; Li L; Li H; Zhai Y; Feng X; Liu S; Zhang W; Linghu E
Can J Gastroenterol Hepatol; 2022; 2022():2349940. PubMed ID: 35782636
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial.
Barret M; Pioche M; Terris B; Ponchon T; Cholet F; Zerbib F; Chabrun E; Le Rhun M; Coron E; Giovannini M; Caillol F; Laugier R; Jacques J; Legros R; Boustiere C; Rahmi G; Metivier-Cesbron E; Vanbiervliet G; Bauret P; Escourrou J; Branche J; Jilet L; Abdoul H; Kaddour N; Leblanc S; Bensoussan M; Prat F; Chaussade S
Gut; 2021 Jun; 70(6):1014-1022. PubMed ID: 33685969
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
Yan L; Zhang M; Song Q; Luo Y
Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
[No Abstract] [Full Text] [Related]
9. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial.
Pouw RE; Klaver E; Phoa KN; van Vilsteren FG; Weusten BL; Bisschops R; Schoon EJ; Pech O; Manner H; Ragunath K; Fernández-Sordo JO; Fullarton G; Di Pietro M; Januszewicz W; O'Toole D; Bergman JJ
Gastrointest Endosc; 2020 Sep; 92(3):569-574. PubMed ID: 32217112
[TBL] [Abstract][Full Text] [Related]
10. The cost effectiveness of radiofrequency ablation for Barrett's esophagus.
Hur C; Choi SE; Rubenstein JH; Kong CY; Nishioka NS; Provenzale DT; Inadomi JM
Gastroenterology; 2012 Sep; 143(3):567-575. PubMed ID: 22626608
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of the effectiveness of radiofrequency ablation in low grade dysplastic Barrett's esophagus.
Pandey G; Mulla M; Lewis WG; Foliaki A; Chan DSY
Endoscopy; 2018 Oct; 50(10):953-960. PubMed ID: 29689573
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness Analysis of Radiofrequency Ablation in Patients With Barrett Esophagus and High-grade Dysplasia or Low-grade Dysplasia.
Federici C; Callea G; Testoni PA; Costamagna G; Trentino P; Repici A
Clin Ther; 2023 May; 45(5):426-436. PubMed ID: 37137786
[TBL] [Abstract][Full Text] [Related]
14. Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes.
Cha DI; Lee MW; Hyun D; Ahn SH; Jeong WK; Rhim H
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958370
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: efficacy, safety and cost-comparison.
Ertan A; Zaheer I; Correa AM; Thosani N; Blackmon SH
World J Gastroenterol; 2013 Nov; 19(41):7106-13. PubMed ID: 24222954
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cyanoacrylate glue and radiofrequency ablation techniques in the treatment of superficial venous reflux in CEAP 6 patients.
O'Banion LA; Reynolds KB; Kochubey M; Cutler B; Tefera EA; Dirks R; Kiguchi MM
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1215-1221. PubMed ID: 33453440
[TBL] [Abstract][Full Text] [Related]
18. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
[TBL] [Abstract][Full Text] [Related]
19. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia.
Wang NJ; Chai NL; Tang XW; Li LS; Zhang WG; Linghu EQ
World J Gastrointest Oncol; 2022 Mar; 14(3):724-733. PubMed ID: 35321273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
